Maximo F. Nougues - Aug 2, 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role
Chief Financial Officer
Signature
/s/ Gordon Esplin as attorney-in-fact for Maximo F. Nougues
Stock symbol
PBYI
Transactions as of
Aug 2, 2022
Transactions value $
-$465
Form type
4
Date filed
8/4/2022, 09:34 PM
Previous filing
Aug 4, 2022
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBYI Common Stock Sale -$465 -161 -0.14% $2.89 112K Aug 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.